Brief: Grand Pharmaceutical Group Posts Normalized Profit For Year Attributable RMB2,036.24 Million
20/03/2024 01:40
March 20 (Reuters) - Grand Pharmaceutical Group Ltd
0512.HK :
* NORMALIZED PROFIT FOR YEAR ATTRIBUTABLE RMB 2,036.24
MILLION,
DECREASE OF 4.7%
* RECOMMENDS PAYMENT OF FINAL DIVIDEND OF 26 HK CENTS PER
SHARE
* FY REVENUE OF HK$10,529.59 MILLION, UP 10.1%
Further company coverage: 0512.HK
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Grand Pharmaceutical
See all newsBrief: Grand Pharmaceutical Group Declares No Interim Dividend Has Been Paid
Grand Pharmaceutical H1 revenue rises on nuclear medicine demand
Grand Pharma rises most in over a year as drug gets US FDA fast track designation
GPN01530-2 Granted Fast Track Designation By FDA
Brief: Grand Pharmaceutical Group Enters Huadong Medicine Supply Agreement